ZA202104509B - Tableted cannabinoid chewing gum with layered structure - Google Patents

Tableted cannabinoid chewing gum with layered structure

Info

Publication number
ZA202104509B
ZA202104509B ZA2021/04509A ZA202104509A ZA202104509B ZA 202104509 B ZA202104509 B ZA 202104509B ZA 2021/04509 A ZA2021/04509 A ZA 2021/04509A ZA 202104509 A ZA202104509 A ZA 202104509A ZA 202104509 B ZA202104509 B ZA 202104509B
Authority
ZA
South Africa
Prior art keywords
chewing gum
composition
water
layer
layered structure
Prior art date
Application number
ZA2021/04509A
Other languages
English (en)
Inventor
Heidi Ziegler Bruun
Dorte Schackinger Boesen
Ane Eriksen
Original Assignee
Nordiccan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA3035400A external-priority patent/CA3035400C/en
Priority claimed from US16/289,770 external-priority patent/US10799450B2/en
Application filed by Nordiccan As filed Critical Nordiccan As
Publication of ZA202104509B publication Critical patent/ZA202104509B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
    • A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Confectionery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA2021/04509A 2019-03-01 2021-06-29 Tableted cannabinoid chewing gum with layered structure ZA202104509B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA3035400A CA3035400C (en) 2019-03-01 2019-03-01 Tableted cannabinoid chewing gum with layered structure
US16/289,770 US10799450B2 (en) 2019-03-01 2019-03-01 Tableted cannabinoid chewing gum with layered structure
PCT/DK2019/050308 WO2020177819A1 (en) 2019-03-01 2019-10-10 Tableted cannabinoid chewing gum with layered structure

Publications (1)

Publication Number Publication Date
ZA202104509B true ZA202104509B (en) 2023-12-20

Family

ID=68617969

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2021/04509A ZA202104509B (en) 2019-03-01 2021-06-29 Tableted cannabinoid chewing gum with layered structure

Country Status (9)

Country Link
EP (2) EP3876744B1 (https=)
JP (1) JP7601779B2 (https=)
CN (1) CN113423279A (https=)
AU (1) AU2019432306B2 (https=)
BR (1) BR112021012489A2 (https=)
ES (1) ES2970150T3 (https=)
MX (1) MX2021008938A (https=)
WO (1) WO2020177819A1 (https=)
ZA (1) ZA202104509B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12383591B2 (en) * 2019-11-12 2025-08-12 London Pharmaceuticals And Research Corporation Chewing gum containing synergistic medicinal compounds
WO2024227046A2 (en) * 2023-04-28 2024-10-31 Whelpley Gordon Brittain Iii Spray application of water-soluble actives to drinking vessels and other objects

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU71919A1 (https=) * 1975-02-26 1977-01-06
GB0216413D0 (en) * 2002-07-15 2002-08-21 Nestle Sa Tabletted chewing gum sweet
EP1449525A1 (en) * 2003-02-20 2004-08-25 Cross Chem Llc chewing gum in the form of multi-layer tablets
EP1554935A1 (en) * 2004-01-19 2005-07-20 Gumlink A/S Layered chewing gum tablet
DK200401195A (da) * 2004-08-06 2004-08-06 Gumlink As Layered chewing gum tablet
WO2006063189A2 (en) * 2004-12-10 2006-06-15 Novartis Ag Multi-layered chewing gum tablet with quick disintegration layer
DK2229156T3 (en) * 2007-12-20 2017-02-06 Fertin Pharma As CHEW GUM TABLE AND PROCEDURE FOR DOSING PHARMACEUTICAL ACTIVE INGREDIENTS IN SUCH CHEW GUM TABLE
LT2280687T (lt) 2008-03-26 2019-08-26 Stichting Sanammad Kramtomosios gumos kompozicijos, apimančios kanabinoidus
JP2010252816A (ja) * 2010-08-23 2010-11-11 Gumlink As 圧縮チューインガムタブレット
US20140083878A1 (en) * 2012-09-21 2014-03-27 Mylan Inc. Transdermal drug delivery device
HK1247084A1 (zh) * 2015-02-02 2018-09-21 APIRx Pharmaceuticals, LLC 大麻素和糖醇复合物，制备和使用的方法
CA3000862C (en) * 2015-10-07 2023-03-14 Medcan Pharma A/S Medical chewing gum comprising cannabinoid
EP3463287B1 (en) * 2016-05-27 2026-01-28 NordicCan A/S Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin
WO2018102296A1 (en) * 2016-11-29 2018-06-07 Axim Biotechnologies, Inc. Chewing gum composition comprising cannabinoids and gabapentin
US20170265494A1 (en) * 2017-06-05 2017-09-21 International Consolidated Companies, Inc. Chewing gum including nanozome encapsulated cannabidiol

Also Published As

Publication number Publication date
EP3876744A1 (en) 2021-09-15
EP4306105A3 (en) 2024-04-10
JP7601779B2 (ja) 2024-12-17
EP3876744B1 (en) 2023-12-06
EP4306105A2 (en) 2024-01-17
AU2019432306B2 (en) 2023-01-05
JP2022521711A (ja) 2022-04-12
BR112021012489A2 (pt) 2021-10-26
EP3876744C0 (en) 2023-12-06
MX2021008938A (es) 2021-08-24
AU2019432306A1 (en) 2021-07-08
WO2020177819A1 (en) 2020-09-10
ES2970150T3 (es) 2024-05-27
CN113423279A (zh) 2021-09-21

Similar Documents

Publication Publication Date Title
ZA202104509B (en) Tableted cannabinoid chewing gum with layered structure
MX395710B (es) Composiciones gomosas de multicomponentes con nucleo duro.
Reichart et al. Dental implants in patients with oral mucosal diseases–a systematic review
CA2582289C (en) Inhibition of tumour cell migration
CO6341541A2 (es) Composiciones para el cuidado oral que comprenden capsulas
NO20090100L (no) Kontrollert frigjoringssystem for fremstilling derav
WO2019126216A8 (en) Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
MXPA04007980A (es) Preparado farmaceutico de sabor enmascarado en forma de pelicula o de oblea.
CY1109905T1 (el) Συνθεσεις που περιεχουν ως δραστικο συστατικο στοιχεια απο σπερμα salvia sclarea
WO2007126651A3 (en) Breath freshening and oral cleansing products with synergistic combinations of magnolia bark extract and essential oils
ECSP024341A (es) Composiciones farmaceuticas
MX391480B (es) Formulaciones farmaceuticas que comprenden pilocarpina.
AR052038A1 (es) Composicion para el cuidado bucal que comprende un compuesto fenolico y vitaminas y derivados de vitaminas antioxidantes
WO2020044119A3 (en) Oral formulations of lavender and cannabinoids
EP4289423A3 (en) An oral cannabinoid tablet
MX2007006343A (es) Forma farmaceutica multiparticulada que comprende ingredientes activos de acido nucleico mucoadhesivamente formulado y un proceso para producir la forma farmaceutica.
GT200600500A (es) Composición farmacéutica orodispersable para la administración oromucosal o sublingual de la agomelatina
MY210445A (en) Flowpack for oral delivery of active ingredients
HUP0402488A2 (hu) Enteroszolvens bevonatú, tablettázott orális gyógyászati készítmény, amely savas közegben labilis benzimidazolvegyületet tartalmaz
ATE553748T1 (de) Emulsionen enthaltend gummi arabicum
MX2025008705A (es) Sistema para el suministro oral de un ingrediente activo
AR046102A1 (es) Forma de dosificacion farmaceutica de liberacion prolongada
Arancibia et al. Triclosan inhibits tumor necrosis factor‐α‐stimulated urokinase production in human gingival fibroblasts
MX2022007261A (es) Composiciones para el cuidado oral y metodos de uso.
TN2021000176A1 (en) Pharmaceutical composition containing acetominophen and ibuprofen